GNOM ETF (Global X Genomics & Biotechnology ETF) is managed by Global X by mirae Asset with $51.4M in net assets. GNOM expense ratio is 0.50%, holding 51 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2019-04-05.

GNOM performance shows a YTD return of 2.64%. The 1-year return is 27.30% and the 5-year return is -13.17%. GNOM dividend yield stands at 1.33%, paid semi-annually.

GNOM top holdings include Moderna therapeutics (6.4%), Arrowhead Pharmaceuticals Inc (6.2%), Praxis Precision Medicines, Inc. (5.7%), Guardant Health, Inc (5.4%), Illumina, Inc. (5.2%). View all GNOM holdings, sector breakdown, or dividend history.

GNOM can be compared against other funds using the overlap calculator or side-by-side comparison tool. GNOM alternatives are available via the screener, along with tax-loss harvesting opportunities.